Skip to main content

Company

Pfizer

697 published works

  1. Drug & Device Law

    Second Circuit Dismisses Suit Challenging Twitter Shutout of Covid-19 Policy Critic

    By Stephen McConnell

    We have covered several vaccine cases over the last few months, but Berenson v. Gottlieb et al., 2026 WL 3135334 (2d Cir. Oct. 20, 2026), is of a different sort. The plaintiff…

  2. FCPA Professor

    A Focus On Central Europe

    By Mike Koehler

    Previous posts have highlighted FCPA enforcement actions concerning conduct (in whole or in part) Greece, Georgia and Ukraine, and Poland. This post highlights FCPA enforcement actions concerning conduct (in whole…

  3. Drug & Device Law

    Connecticut Court Torpedoes Multi-Plaintiff Joinder

    By Eric Hudson

    Sometimes we get a little tired of plaintiffs’ antics in bringing multi-plaintiff complaints to defeat diversity jurisdiction or tilt the scales in their favor at trial.  Federal courts are generally…

  4. Wait A Second!

    Anti-Biden Twitter critic loses federal civil rights suit alleging conspiracy to close his account

    By secondcircuitcivilrightsblogsecondcircuitcivilrig

    The plaintiff here was an active Twitter-poster who criticized President Biden's COVID-19 policies, challenging the shutdowns and school closures. Twitter eventually suspended him under its five-strikes-yer-out rule after determining he…

  5. Spicy IP

    SpicyIP Weekly Review (September 28- October 4)

    By SpicyIP

    Beating the Monday blues after a long weekend, here we are with the first Weekly Review of October, featuring a post on Section 124, case summaries of orders passed by…

  6. SALT Shaker

    Alabama prescribes an addback on intercompany interest

    By Jeffrey Friedman, Madison Ball

    The Alabama Court of Civil Appeals affirmed a trial court’s determination that Pfizer could not deduct interest paid to its related Irish affiliate, finding that the “subject-to-tax exception” did not…

  7. The CLS Blue Sky Blog

    White & Case Discusses M&A Regulatory Closing Risk and Superior-Proposal Determination

    By Renholding

    In the fourth quarter of 2025, Novo Nordisk A/S (“Novo”) intervened as an interloper in the acquisition of Metsera, Inc. (“Metsera”), a clinical-stage developer of obesity and metabolic therapies that…

  8. Spicy IP

    SpicyIP Weekly Review (September 7- September 13)

    By SpicyIP

    After another busy week and a long weekend, here we are with the SpicyIP Weekly Review with discussions on the Delhi High Court’s evolving approach to personality rights, a closer…

  9. Gadgets, Gigabytes & Goodwill Blog

    The One-Carbon Mistake That Cost A Patent Its Priority Date

    By Puya Partow-Navid

    Nobody likes the grammar police. Patent lawyers, unfortunately, may be the exception. In Enanta Pharmaceuticals, Inc. v. Pfizer Inc. No. 2025-1427 (Fed. Cir. June 23, 2026), one character did a…

  10. Patent Law Weblog

    Moderna Appeals District Court Infringement Judgment over COVID Vaccines

    By Zuhn21b31b8b84f

    By Kevin E. Noonan –One of the beneficial characteristics of the response to the COVID-19 pandemic were pledges from companies involved in developing vaccines (such as Moderna, Pfizer, BioNTech, and…